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Abstract
The effect of inhomogeneous static magnetic field (SMF)-exposure on the production of different cytokines from human
peripheral blood mononuclear cells (PMBC), i.e., lymphocytes and macrophages, was tested in vitro. Some cultures were
activated with lipopolysaccharide (LPS) at time point 23 h and were either left alone (positive control) or exposed to SMF
continuously from 0 until 6, 18, or 24 h. The secretion of interleukin IL-6, IL-8, tumor necrosis factor TNF-a, and IL-10 was
tested by ELISA. SMF-exposure caused visible morphological changes on macrophages as well as on lymphocytes, and also
seemed to be toxic to lymphocytes ([36.58; 41.52]%, 0.308#p#0.444), but not to macrophages (,1.43%, p$0.987). Analysis
of concentrations showed a significantly reduced production of pro-inflammatory cytokines IL-6, IL-8, and TNF-a from
macrophages compared to negative control ([56.78; 87.52]%, p = 0.031) and IL-6 compared to positive control ([45.15;
56.03]%, p= 0.035). The production of anti-inflammatory cytokine IL-10 from macrophages and from lymphocytes was
enhanced compared to negative control, significantly from lymphocytes ([2183.62; 228.75]%, p = 0.042). The secretion of
IL-6 from lymphocytes was significantly decreased compared to positive control ([2115.15; 226.84]%, p= 0.039). This
massive in vitro evidence supports the hypotheses that SMF-exposure (i) is harmful to lymphocytes in itself, (ii) suppresses
the release of pro-inflammatory cytokines IL-6, IL-8, and TNF-a, and (iii) assists the production of anti-inflammatory cytokine
IL-10; thus providing a background mechanism of the earlier in vivo demonstrated anti-inflammatory effects of SMF-
exposure.
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Introduction
Today, due to the preceding research work and its dissemina-
tion, it is widely accepted that static magnetic field (SMF)-exposure
can achieve well defined observable responses from cells and living
subjects under a broad range of experimental and clinical
physiological and pathological conditions [1–5]. In contrast to
the number of phenomenological observations and descriptions,
little knowledge has accumulated about the background mecha-
nisms of action [6], although the elective site of action of SMF
seems to be the plasma membrane [7–9]. The probable reason for
this is the lack of systematic research. Valuable experiments and
clinical trials could not contribute to overall research as much as
they would have deserved due to incomplete description of
different magnetic inductions and their spatial gradients repre-
senting a 6D space, magnet arrangements, etc. Missing published
data often hinder the replication of otherwise extremely important
and valuable research projects.
The most frequent use of SMF-exposure is represented in MRI
(Magnetic Resonance Imaging) devices nowadays. Although the
MRI diagnosis requires 3 different types of magnetic fields, the B0
component is static. Research concerning the biological effects of
SMF-exposure in humans diverges into two paths: the compilation
of (i) epidemiological evidence that SMF-exposure does not imply
health hazards and conversely, (ii) evidence of beneficial effects
may raise SMF-exposure into an evidence-based medical therapy
option. Reviews on the topic are available from WHO (World
Health Organization) [10] and more recently from SCENIHR
(Scientific Committee on Emerging and Newly Identified Health
Risks) of the European Commission [11]. Russian scientists were
specifically devoted to clarify the mechanisms behind magneto-
therapy (meaning electromagnetic field irradiation); for a recent
review see [12].
In particular, the production of pro-inflammatory cytokines
interleukin IL-6 and tumor necrosis factor TNF-a, and that of the
anti-inflammatory cytokine IL-10 was studied in the work of
Salerno et al. [13] in vitro on human peripheral blood mononuclear
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cells (PBMC) under 0.5 T SMF continuous exposure for 24 h.
The authors did not find any significant changes in the release of
any cytokines. Aldinucci et al. [14] published similar conclusions of
a similar study concerning pro-inflammatory cytokines IL-6 and
TNF-a on identical subject cells as Salerno et al. [13], but the
magnetic induction was continuous 4.75 T for 1 h. IL-8 was
monitored by Sontag [15] in his in vitro study on human
promyelocite cells (HL-60) exposed to 0–1.2 mT for a time period
of 15 min. He neither found significant differences to unexposed
control. Lin et al. [16] executed an in vivo experimental series on
mice. A group of mice was exposed to SMF of 0.25 T for 2 h
preceding a 50 mg/kg lipopolysaccharide (LPS) challenge. The
authors did not find any significant change in the IL-6 and TNF-a
secretion levels compared to positive control (LPS challenge only).
However, Wang et al. [17] exposed human embryoid body derived
cells to 0.23–0.28 T for 1–4 days continuously and found a
significant increase in the release of IL-6.
If in vitro evidence was found on the SMF-exposure induced
inhibition or assistance of the release of pro- and anti-inflamma-
tory cytokines, a possible background mechanism of in vivo
experienced antinociceptive effects in invertebrates [18], in mice
[19–25], and in humans [26] would be supported. Therefore, the
present set of in vitro experiments was designed to prove the null-
hypotheses that exposure of PBMC to an inhomogeneous SMF for
up to 24 h leads to a significant change in the:
1) production of IL-6, IL-8, TNF-a, and IL-10 compared to
negative (unexposed) control;
2) LPS-activated production of IL-6, IL-8, TNF-a, and IL-10
compared to positive (LPS-activated, unexposed) control.
Materials and Methods
Ethics Statements
Human blood samples were obtained by buffy coats supplied by
the Hospital S. Giuseppe da Copertino, Lecce, Italy. Donors were
anonymous to us. The need of donor consent was waived by the
Ethics Committee. The use of buffy coat was acknowledged by the
Comitato Etico dell’ASL LE, Lecce, Italy (Ethics Committee of the
Health Service of Lecce). This Ethics Committee is an indepen-
dent organization that is working under the Declaration of
Helsinki and following the rules of Good Clinical Practices
according to international and national laws and to the guidelines
of the Italian National Committee of Bioethics.
SMF-exposure
SMF was generated with an exposure system described in
details as generator #11 in [19]. Shortly, the device consisted of
an upper and lower iron plate covered with 10610 mm cylindrical
neodymium-iron-boron (NdFeB) N50 grade magnets
(Br=1.47 T). The lateral periodicity of the SMF was 10 mm.
The individual magnets on both plates were placed next to each
other with alternating polarity. Magnets facing each other on the 2
plates were oriented with opposite polarity. The plates were fixed
in a holder with 50 mm vertical separation between the upper and
lower magnet arrays thus realizing an exposure chamber size
1406140646 mm. Magnetic coupling applied between the
matrices (the upper and lower magnet arrays were coupled
through vertical ferromagnetic plates). Magnetic field mapping
was performed separately from the in vitro experiments by means
of a 5 V calibrated ratiometric linear Hall-effect sensor of
12.3 mV/T sensitivity (model UGN3503, Allegro MicroSystems,
Worcester, MA, USA). The typical peak-to-peak magnetic
induction values along the axis of a NdFeB magnet in the
isocenter were 476.760.1, 12.060.1, and 2.860.1 mT, whereas
the average lateral gradient values between 2 neighbouring local
extremes were 47.7, 1.2, and 0.3 T/m at 3, 15, and 25 mm from
the surfaces of plates, respectively. Horizontal components of the
SMF in the exposure chamber and all components of Earth’s
magnetic field were regarded as stray field. Control samples were
exposed to the geomagnetic field, magnetic induction values of
which were about 4 orders of magnitude lower than those at the
target position in the exposure chamber.
Cells, Chemicals
PBMC (monocytes and lymphocytes) were isolated from human
buffy coats of non-smoker healthy male donors between 24 and 45
years of age by Ficoll gradient separation. Over 95% pure
peripheral blood lymphocytes were separated from monocytes by
overnight adherence to plastic. Cells were cultured in 25 cm2 flasks
(Iwaki, Tokyo, Japan) at a cell density of 105 cells/ml in RPMI-
1640 medium (Cambrex BioScience, Verviers, Belgium) supple-
mented with 10% (v/v) heat-inactivated fetal calf serum (Cam-
brex), 2 mM L-glutamine (Cambrex), 100 IU/ml penicillin and
streptomycin in a humidified atmosphere of 5% CO2 at 37uC.
Some cultures of monocytes and lymphocytes were activated with
1 mg/ml LPS for 3 h first and then were exposed to SMF for 6, 18,
or 24 h. Controls cells were cultured under the same culture
conditions, but remained unexposed to SMF. All chemicals were
of analytical grade and were provided by Sigma-Aldrich (St. Louis,
MO, USA) unless otherwise indicated. Optical density (OD) values
were read by spectrophotometer (Ultrospec 4000 UV/Visible
Spectrophotometer, Pharmacia Biotech, Stockholm, Sweden) at
450 nm (OD450).
Light Microscope Observations
An Eclipse TS100 (Nikon, Kawasaki, Kanagawa Prefecture,
Japan) inverted microscope was used to investigate morphological
cellular shape changes also at time points 0, 6, 18, and 24 h.
Cytokine Assays
Production of different cytokines: IL-6 (monocytes and
lymphocytes), IL-8 (monocytes), IL-10 (monocytes and lympho-
cytes), and TNF-a (monocytes) were determined by ELISA (R&D
Systems, Minneapolis, MN, USA) from the supernatants at time
points 0, 6, 18, and 24 h.
Timeline
The timeline of the experiment can be seen in Fig. 1.
Statistics
The primary outcome measure was the average OD450 value of
a specific culture under a certain treatment at a given time point.
Concentrations were derived from these values. First the best
standard curve (r2 = 99%) was set in accordance with the
manufacturer’s instructions by plotting known concentrations of
a certain cytokine expressed in pg/ml vs the relative OD450 read.
Then we interpolated between known average OD450 values to get
the desired concentration of the given cytokine.
Statistical measures were analyzed in a 2-sided manner in
accordance with the null-hypotheses. Balanced, self-controlled
group analysis of variances (2-way rANOVA) was applied for the
estimate of the OD450 differences due to treatments. The
treatment options and the time points were the factors. Treatment
options were: none (negative control), LPS (positive control), SMF,
or SMF+LPS. Time points were: 0, 6, 18, and 24 h. One-way
Evidence of SMF-Exposure Suppressing Inflammation
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ANOVA was applied in case of the concentrations. Games-Howell
test was used for post hoc analysis of binary comparisons within time
points (n=9) and also in case of concentrations (n=4 for negative
and positive controls, n=3 for SMF and SMF+LPS). A difference
between group averages upon different treatments was accepted
significant, if p,0.05 at the 95% confidence level. Probabilities
below 0.001 are not shown numerically in the text.
Effect between treatment options i and j at a given k time point
was defined as 100 1{ SODikTSODjkT
 
in percent, where SODikT and
SODjkT are averages of OD450 values at a given k time point,
n=9/treatment. i could only be SMF or SMF+LPS, the
corresponding j could only be negative or positive (LPS) control,
respectively. By definition the effect can be positive (inhibition) or
negative (assistance). Concentrations (pg/ml), viabilities as well as
effects (%) are presented in column graphs. Positive error bars in
the figures denote standard deviation (SD). Identically scaled y
axes were used for the presentation of effects allowing for
immediate visual comparison.
Results
Time-dependent cell shape modifications have been observed
on SMF-exposed cells (on macrophages to a higher extent than on
lymphocytes) all through the experiment. Fig. 2A and B show the
morphological changes of macrophages and lymphocytes under
different treatments negative control, positive control (LPS), SMF,
and SMF+LPS. In particular, at time point 24 h macrophages
showed an elongated shape while lymphocytes exhibited cell
surface ruffling and indentations.
Viability of cells was controlled. Fig. 3A and B show the number
of viable macrophages and lymphocytes, respectively at the
baseline and at 24 h. Even if the spontaneous death of
macrophages was about 49.81% during this period, none of the
treatments seemed to have affected the procedure (remained
between 50.31% and 51.09%). The maximum effect at 24 h
between differently treated cultures to each other was 2.54% (LPS
to negative control at 24 h). Lymphocytes showed higher
sensitivity to the treatments: meanwhile apoptosis decreased the
number of viable cells to 67.80% of the baseline value at 24 h,
LPS caused a reduction of 92.50% only, but SMF alone 50.83%,
and in combination with LPS 56.68% as compared to negative
control at 24 h.
Fig. 4A, B, C, and D show time-resolved concentration data for
macrophages producing IL-6, IL-8, and TNF-a pro-inflammatory
cytokines, and IL-10 anti-inflammatory cytokine, respectively.
Different shades of the columns denote different time periods (0, 6,
18, and 24 h); treatment options are the independent variables. *
and6mean significant differences p,0.05 compared to negative
control and to positive control (LPS), respectively. For the 6–24 h
time interval ANOVA provided Fcrit = 4.07 for all cases analyzed
and F=27.92 (p,0.001), F=3.13 (p=0.087), F=4.15 (p=0.048),
and F=0.47 (p=0.709) for IL-6, IL-8, TNF-a, and IL-10,
respectively.
Similarly to Fig. 4, Fig. 5A and B show the time-resolved
concentrations for lymphocytes producing IL-6 and IL-10,
respectively. Different shades and marks (* and6) have the same
meaning as in Fig. 4. ANOVA resulted in F=4.88 (p=0.033) and
F=3.01 (p=0.095) for IL-6 and IL-10, respectively.
SMF-exposure was more efficient on macrophages than on
lymphocytes, since macrophages secreted more cytokines than
lymphocytes. Without taking the time-dependence into account at
baseline, when no SMF treatment was yet used, but LPS had been
given for 3 h already, the secretion of IL-6 and IL-8 from
macrophages and IL-6 from lymphocytes started. LPS-activation
hardly induced TNF-a production in the first 3 h. LPS as an
activator seemed to work well in the model for macrophages as
well as for lymphocytes mimicking the inflammatory situation
in vitro: it enhanced the secretion of IL-6 significantly from
lymphocytes (250.61%, p,0.001 estimated by rANOVA), and
the secretion of IL-6 (223.33%, p,0.001), IL-8 (217.04%,
p,0.001), and TNF-a as well (223.09%, p,0.001) from
macrophages. LPS also induced a tendency to increase IL-10
release beyond the first 6 h. LPS-activated cells in the absence of
SMF secreted the highest amounts of IL-8 at all times compared to
negative control.
The effect of cytokine release due to SMF-exposure was based
on raw OD450 data, the time-dependent viability of cells was not
considered. Positive or negative effect means if a treatment
decreases or increases the OD450 values compared to respective
control. All figures show a y axis with identical scale for easy visual
comparison. The effect of SMF acting on cytokine secretion from
macrophages compared to negative and positive control can be
seen in Fig. 6A and B. The numerical results of probabilities of
significance based on OD450 values are collected in Table 1.
Figure 1. Timeline of the experiment. LPS stands for lipopolysac-
charide, SMF for static magnetic field.
doi:10.1371/journal.pone.0072374.g001
Figure 2. Evaluation of morphological changes. Light microscope
images of the morphological changes of A) macrophages and B)
lymphocytes. Negative control: no treatment; LPS: lipopolysaccharide-
activation; SMF: static magnetic field-exposure; SMF+LPS: SMF-exposure
combined with LPS-activation. Bar length = 10 mm. The time axis is out
of scale.
doi:10.1371/journal.pone.0072374.g002
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Similarly to Fig. 6A and B, the effect of SMF on cytokine release
from lymphocytes compared to negative and positive control can
be seen in Fig. 7A and B, respectively.
SMF-exposure alone induced an anti-inflammatory response of
macrophages and lymphocytes by strongly and significantly
inhibiting the secretion of pro-inflammatory cytokines IL-6, IL-
8, and TNF-a as compared to negative control. The effect of
SMF-exposure on IL-10 anti-inflammatory cytokine presented an
opposite trend; a moderate, but significant assistance could be
seen.
Figure 3. Evaluation of cell viability. Number of viable A) macrophages and B) lymphocytes at baseline and at 24 h. Cultures were exposed to
different treatments: negative control: no treatment; LPS: lipopolysaccharide-activated; SMF: SMF-exposed; LPS+SMF: lipopolysaccharide-activated
and SMF-exposed.
doi:10.1371/journal.pone.0072374.g003
Figure 4. Cytokine profile release by macrophages. Concentration of A) IL-6, B) IL-8, C) TNF-a, and D) IL-10 released from macrophages in 24 h
under different treatments. Positive error bars show standard deviation (SD) values. * and6denote significant differences (p,0.05) to corresponding
negative or positive control (LPS), respectively as estimated with Games-Howell post hoc analysis.
doi:10.1371/journal.pone.0072374.g004
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LPS-activated cells in the presence of SMF strongly and
significantly inhibited the secretion of pro-inflammatory cytokine
IL-6, IL-8, and TNF-a from macrophages. These effects were
significant. A surprising negative and with time monotonously
decreasing effect occurred in case of IL-6 release from lympho-
cytes. The production of anti-inflammatory cytokine IL-10
underwent a slight, hardly significant inhibition as compared to
positive control from either macrophages, or lymphocytes. The
time dependence of the effect of cytokine secretion manifested
itself in a monotonous rise in the inhibition in case of IL-6 for both
sources compared to either control, but for lymphocytes compared
to positive control. IL-8 production hardly varied with time
following 6 h. TNF-ainhibition basically decreased with time,
while IL-10 was the only examined cytokine the production of
which correlated with the source, the absolute value of the assisting
effect decreased in time for macrophages and increased for
lymphocytes compared to negative control. LPS-activation in the
presence of SMF-exposure had a mild effect (below 20%) on the
release of IL-10 for either source. Meanwhile, SMF-exposure from
macrophages showed a trend of diminishing action of the release
of cytokines with the time of exposure, the action from
lymphocytes seemed to be gradually enforced.
Statistical analysis (see Table 1 for a comprehensive view) of the
concentrations showed that null-hypothesis 1 (i.e., effect of SMF-
exposure to negative control) held for IL-6, IL-8, and TNF-a for
6–24 h with a significant inhibition between 56.78% and 87.52%
for the release of cytokines from macrophages hindering the
production of pro-inflammatory cytokines. SMF-exposure basical-
ly remained ineffective on the IL-6 release from lymphocytes
(,|12.20%|). SMF-exposure assisted the release of anti-inflam-
matory cytokine IL-10 from macrophages as well as from
lymphocytes (between 2183.62% and 26.45%) significantly for
lymphocytes, insignificantly for macrophages. Null-hypothesis 2
(i.e., effect of SMF-exposure to positive control) also held for all
pro-inflammatory cytokines. Pro-inflammatory cytokine release
was inhibited from macrophages (effect of 0.15%–56.03%) by the
SMF-exposure (significantly for IL-6), while exposure surprisingly
significantly assisted the release of IL-6 from lymphocytes (between
2115.15% and 226.84%). Anti-inflammatory cytokine IL-10
Figure 5. Cytokine profile release by lymphocytes. Concentration of A) IL-6 and B) IL-10 released from lymphocytes in 24 h under different
treatments. Positive error bars show SD values. * and6denote significant differences (p,0.05) to corresponding negative or positive control (LPS),
respectively as estimated with Games-Howell post hoc analysis.
doi:10.1371/journal.pone.0072374.g005
Figure 6. Effect of SMF exposure on cytokine release by macrophages. Effect of cytokine release from macrophages under SMF-exposure
compared to A) negative and B) positive (LPS) control, respectively as estimated from OD450 data. * and6denote significant differences (p,0.05) to
negative and positive control, respectively. Positive effect means inhibition, negative means assistance. Probabilities of significance can be found in
Table 1.
doi:10.1371/journal.pone.0072374.g006
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release from macrophages was mildly and insignificantly inhibited
from macrophages and assisted from lymphocytes.
Discussion
Normally unstimulated human primary PBMC undergo spon-
taneous cell death in culture. This is the reason why the decrease
in the viability of macrophages as well as lymphocytes in the
cultures together with the withdrawal of the release of pro-
inflammatory cytokines IL-6, IL-8, TNF-a, and the increase of
anti-inflammatory cytokine IL-10 was happening simultaneously
in the present experiment. In previous studies it was already
demonstrated that 6 mT SMF-exposure applied for up 24 h to
human U937 promonocytic cells [1] or to freshly isolated human
lymphocytes [3] did not significantly exert any toxic or apopto-
genic effect. However, in agreement with the data reported here
(Fig. 2), 6 mT SMF-exposure affected cell shape [7] as a result of
cytoskeleton rearrangements [1] or by influencing the structural
components of plasma membrane directly [9].
In the present study, the effects observed on macrophages can
be directly compared without weighting with the degree of lost
viability, since the number of macrophages hardly depended on
the treatment options (including no treatment) in the first 24 h
period.
It is certainly interesting in itself what a strong adverse effect
SMF-exposure exerted on the viability of lymphocytes. Although
previous in vitro studies suggested otherwise for extremely weak
SMF on human lymphocytes [3], the authors attribute the effect to
the magnetic induction at the target site in the present
experimental series. Namely, magnetic induction exceeded 6 mT
by almost 2 orders of magnitude at average peak-to-peak value.
On the other hand, the elevated level of cell death is in harmony
with the results presented by Lee et al. [27], who found severe
DNA breaks due to exposure with a combined magnetic field of a
3 T clinical MRI running different scanning protocols for
durations between 22 and 89 min in vitro on human lymphocytes.
There is an opposition in the dependence of the SMF-exposure
induced cytokine releasing action on macrophages and lympho-
cytes as a function of exposure duration. Lymphocytes are fully
differentiated cells, while macrophages – in the absence of specific
inducers – are not fully differentiated. Thus, lymphocytes and
(monocyte-derived) macrophages have different genetic expres-
sion. This is in accordance with the different roles of the cells:
macrophages may produce cytokines immediately upon stress; the
production of cytokines by lymphocytes however, is of secondary
importance for the lymphocytes. As against macrophages,
lymphocytes use receptors to bind antigens, and the role of
SMF-exposure on some receptors has already been shown [21,28].
Therefore, we might hypothesize that the response evoked by
strong SMF-exposure could be different for lymphocytes and
macrophages as already demonstrated by Tenuzzo et al. [2] for
6 mT SMF-exposure.
Gyires et al. [21] published a classical pharmacological analysis
of the action of SMF-exposure in a mouse model of acute visceral
pain with the same SMF generators as used in the present study.
They discovered the significant role of opioid receptors, especially
that of m-opioid receptors, and also succeeded in excluding the
contribution of k-opioid receptors. The authors speculated that the
strong analgesic effect of SMF-exposure may have been due to the
release of either/both b-endorphin or/and endomorphin-2 in the
spinal cord. Later La´szlo´ and Herna´di [18] verified in Helix
pomatia, in a land snail model that the thermal nociceptive
threshold depended on the preceding 20–40 min long SMF-
exposure to either homogeneous SMF of 147 mT or to an
inhomogeneous SMF-exposure, where SMF was identical to that
present. With the application of naloxone pretreatment they could
reveal the mediatory role of opioid receptors in the SMF-induced
antinociception. There is also evidence collected that low-dose
naloxone with morphine has a similar effect of pro- and anti-
inflammatory cytokines as presented here [29]. This suggests that
the action of SMF-exposure may be similar to that of serum
morphine in the sense that naloxone can moderate both, and the
secretion of pro- and anti-inflammatory cytokines was also
observed.
Sa´ndor et al. [20] used the same SMF generator to prove that
the capsaicin-sensitive fibers also mediated the anti-hyperalgesic
action of SMF-exposure in a mouse acute peripheral pain model.
Carrageenan, TNF-a, IL-6, and IL-8 were reported to induce
hyperalgesia [30]. The downregulation of the pro-inflammatory
cytokines by the SMF-exposure may explain why Sa´ndor et al. [20]
noticed the significant decrease of hyperalgesia induced by
carrageenan in their peripheral pain model. These observations
can now be linked to the altered cytokine release characteristics of
macrophages and lymphocytes from PBMC.
Figure 7. Effect of SMF exposure on cytokine release by lymphocytes. Effect of cytokine release from lymphocytes under SMF-exposure
compared to A) negative and B) positive (LPS) control, respectively as estimated from OD450 data. * and6denote significant differences (p,0.05) to
negative and positive control, respectively. Positive effect means inhibition, negative means assistance. Probabilities of significance can be found in
Table 1.
doi:10.1371/journal.pone.0072374.g007
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The upregulation of IL-6 and TNF-a expression in case of
chronic constriction injury has been shown recently [31]. If SMF-
exposure acts against chronic constriction injury, the extraordi-
nary beneficial effect reported by Antal and La´szlo´ [23] in their
in vivo experiment of a chronic neuropathy mouse model can – at
least partially – be understood. Namely, they used nerve ligature to
achieve neuropathic pain.
SMF-exposure was also shown to significantly prolong the time
of LPS-induced premature birth occurrence [32]. A background
mechanism for this beneficial effect can be the moderation of the
inflammatory response as SMF-exposure acts on the pro-
inflammatory cytokine release.
The present results are in fair harmony with those of Wang et al.
[17], who applied 0.23–0.28 T exposure on human embryoid
body derived cells continuously for 1–4 days. They experienced a
short-term (,24 h) activation of IL-6 involved the coordinate up-
regulation of toll-like receptor-4 (TLR4) with complementary
changes to NEU3 and ST3GAL5 that reduced ganglioside GM3
in a manner that augmented the activation of TLR4 and IL-6.
The authors suggested a plausible mechanism for the attenuation
of cellular responses to SMF by the loss of GM3. They also
observed SMF-mediated morphological changes and biochemical
markers indicative of pre-oligodendrocyte differentiation at the
cellular level.
In conclusion, the present in vitro experiments demonstrate
convincing evidence that exposure to a strong, inhomogeneous
SMF for up to 24 h has a significant inhibitory effect on the release
of pro-inflammatory cytokines IL-6, IL-8, and TNF-a from
macrophages as compared to negative, untreated control. The
assistance SMF-exposure exerts on the production of anti-
inflammatory cytokine IL-10 from lymphocytes was also found
significant. LPS-activation reduces the differences between treated
and untreated cultures, but IL-6 release from macrophages
remains significantly inhibited upon SMF-exposure. The SMF-
exposure assisted release of IL-6 from lymphocytes remains a
challenging effect to be dealt with in the future. The present
experiments may be regarded as proof that SMF-exposure in fact
has a beneficial effect on human macrophages and lymphocytes
in vitro, and as such SMF-exposure should be a worthy candidate
of further investigations in clinical trials including diseases with
inflammatory background.
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